Elsevier

Atherosclerosis

Volume 137, Issue 1, 3 March 1998, Pages 49-61
Atherosclerosis

The antioxidative effects of the isoflavan glabridin on endogenous constituents of LDL during its oxidation

https://doi.org/10.1016/S0021-9150(97)00251-7Get rights and content

Abstract

The effect of the consumption of glabridin, an isoflavan isolated from Glycyrrhiza glabra (licorice) root, on the susceptibility of low density lipoprotein (LDL) to oxidation was studied in atherosclerotic apolipoprotein E deficient (E° mice) and was compared with that of the known flavonoids, quercetin and catechin. Glabridin inhibitory activity on in vitro oxidation of human LDL was also investigated by determining the formation of lipid peroxides and oxysterols and the consumption of LDL-associated lipophilic antioxidants. Determination of the extent of LDL oxidation by measuring the formation of thiobabituric acid reactive substances (TBARS) after 2 h of LDL incubation with CuSO4 (10 μM) or 2,2′-azobis (2-amidino-propane) dihydrochloride (AAPH) (5 mM), revealed that glabridin or quercetin consumption resulted in a 53 and 54% reduction in copper ion induced oxidation, respectively, and a 95 and 83% reduction in AAPH induced LDL oxidation, respectively. No inhibition was obtained with consumption of catechin. About 80% of glabridin was found to bind to the LDL human particle. In the in vitro oxidation of LDL induced by AAPH (5 mM), glabridin inhibited the formation of TBARS, lipid peroxides and cholesteryl linoleate hydroperoxide (CLOOH) at all the concentrations tested (5–60 μM), while in oxidation induced by copper ions (10 μM), glabridin exhibited a pro-oxidant activity at concentrations lower than 20 μM, and a clear antioxidant activity at concentrations greater than 20 μM. Glabridin (30 μM) inhibited the formation of cholest-5-ene-3,7-diol (7-hydroxycholesterol), cholest-5-ene-3-ol-7-one (7-ketocholesterol) and cholestan-5,6-epoxy-3-ol (5,6-epoxycholesterol) after 6 h of AAPH induced LDL oxidation, by 55, 80 and 40%, respectively, and after 6 h of copper ion induced LDL oxidation, by 73, 94 and 52%, respectively. Glabridin also inhibited the consumption of β-carotene and lycopene by 38 and 52%, respectively, after 0.5 h of LDL oxidation with AAPH, but failed to protect vitamin E. The in vivo and in vitro reduction of the susceptibility of LDL to oxidation obtained with glabridin, may be related to the absorption or binding of glabridin to the LDL particle and subsequent protection of LDL from oxidation by inhibiting the formation of lipid peroxides and oxysterols, and by protecting LDL associated carotenoids.

Introduction

Human low density lipoprotein (LDL) is the major cholesterol carrier in the blood stream. It is well established that the cholesterol deposits in the arteries stem primarily from plasma LDL and that increased levels of plasma LDL correlate with an increased risk for atherosclerosis. Various lines of research provide strong evidence that LDL becomes oxidized in vivo and that oxidized LDL is involved in the formation of the early atherosclerotic lesions 1, 2, 3, 4, 5, 6, 7, 8.

Oxidation of LDL involves lipid peroxidation, in which the LDL polyunsaturated fatty acids are rapidly converted into lipid peroxides and into aldehydic lipid peroxidation products [3]. Cholesterol is oxidized during LDL oxidation and high levels of the oxysterol derivatives are found in oxidized LDL 9, 10, 11. Several reports suggest that the oxidation of LDL starts after the depletion of its endogenous lipophilic antioxidants, such as vitamin E, β-carotene, and lycopene 12, 13, 14, 15, 16, 17. Protection of LDL from oxidation is thus an effective strategy to prevent or to retard the progression of atherosclerosis. Compounds that can prevent lipid peroxidation (antioxidants) may increase the resistance of LDL to peroxidation. Lipophilic antioxidants, such as probucol, vitamin E or carotenoids, were shown to protect LDL from oxidation in vitro and in vivo 18, 19, 20, 21, 22, 23, 24, 25, 26, 27.

Plants produce a variety of phenolic antioxidants. Among the various phenolic compounds, the flavonoids are perhaps the most important group [28]. Flavonoids are components of a wide variety of edible plants, fruits, vegetables and grains, and are an integral part of the human diet [29].

Mangiapane et al. [30] demonstrated the ability of catechin, a naturally occurring flavanol derivative, to inhibit LDL oxidation induced by copper ions or by arterial wall cells. De Whalley et al. [31] reported that certain flavone and flavonol derivatives found in the diet significantly inhibited LDL oxidation by macrophages. These flavonoids conserved the vitamin E content of LDL and delayed the onset of detectable lipid peroxidation. It was demonstrated that consumption of red wine with meals reduced the susceptibility of human plasma and LDL to lipid peroxidation [32]. Consumption by atherosclerotic apolipoprotein E-deficient (E° mice) of red wine or of its major flavonoids quercetin, and to a lesser extent catechin, led to attenuation in the development of the atherosclerotic lesion, and this effect was associated with reduced susceptibility of their LDL to oxidation [33]. Extract of the root of Glycyrrhiza glabra (licorice), a plant originating from Asia where it has been employed to treat several diseases 34, 35, successfully reduced the susceptibility of LDL to oxidation 36, 37. Dietary supplementation of E° mice and humans with licorice extract resulted in a substantial reduction in the susceptibility of their LDL to oxidation. An analysis of the mice aortic arch lesions after consumption of licorice, in comparison with mice treated with placebo, was performed. Light microscopy revealed histopathologic atherosclerotic lesion in the aortic arch of both groups of mice, although the incidents of the lesion was far greater in the placebo-treated mice [37]. Four isoflavans, isolated from licorice roots, were found to inhibit LDL oxidation. Glabridin, one of the isoflavans isolated, was the major flavonoid and antioxidant constituent [36]. These isoflavans are considerably more lipophilic than the flavone or flavanol subclasses which were more extensively investigated. The LDL of E° mice fed with glabridin was found to be more resistant to oxidation than LDL from mice fed with placebo [37]. These results indicate that glabridin may be responsible for the effect of licorice in vivo.

In view of the in vivo results obtained with licorice extract and its major constituent glabridin, it is desirable to continue a deeper investigation to determine the mechanism by which glabridin protects LDL from oxidation, affecting the endogenous LDL constituents, such as cholesterol and antioxidants. The aim of the present study was to analyze the effect of glabridin on the consumption of lipophilic endogenous antioxidants and on the formation of cholesteryl linoleate hydroperoxide and oxysterols, during the oxidation of LDL.

Section snippets

Chemicals

Glabridin was isolated from the acetone extract of the roots of Glycyrrhiza glabra (the licorice plant) by liquid–liquid extraction and flash column chromatography [36]. Quercetin, catechin, N,O-bis(trimethylsilyl)acetamide (BSA), cholest-5-ene-3β,7β-diol (7β-hydroxycholesterol), cholest-5-ene-3-ol-7-one (7-ketocholesterol), cholestan-5,6α-epoxy-3-ol (5,6α-epoxycholesterol), cholesterol, cholesteryl linoleate, vitamin E, β-carotene, copper sulfate, ferrous sulfate,

The effect of glabridin, quercetin and catechin supplementation to E° mice on the susceptibility of their LDL to oxidation

Several constituents were isolated and identified from licorice roots, and their antioxidative activities were measured. Glabridin was by far the major component (11.6% w/w in the acetone extract) and among the most actively antioxidant constituents [36]. The supplementation of licorice extract or glabridin to E° mice resulted in the reduction of the susceptibility of LDL to oxidation [37]. Following these results, a comparison of the in vivo effects of glabridin to the known flavonoids

Discussion

The mechanism by which antioxidants inhibit LDL oxidation is uncertain. They may protect endogenous constituents in LDL, such as polyunsaturated fatty acids, lipophilic antioxidants and cholesterol, from oxidation. In the present study, we have shown that glabridin, an isoflavan antioxidant, efficiently bound to LDL, and effectively inhibited the production of lipid peroxides and oxysterols and the consumption of carotenoids. Glabridin was ineffective in protecting vitamin E and in chelating

Acknowledgements

We thank Irena Palui for her technical assistance.

References (76)

  • J. Vaya et al.

    Antioxidant constituents from licorice roots: isolation, structure elucidation and antioxidative capacity towards LDL oxidation

    Free Radical Biol Med

    (1997)
  • B. Fuhrman et al.

    Licorice alcoholic extract and its major polyphenol glabridin protect low-density lipoprotein against lipid peroxidation: in vitro and ex-vivo studies in humans and in atherosclerotic apolipoprotein E-deficient mice

    Am J Clin Nutr

    (1997)
  • M. Aviram

    Plasma lipoprotein separation by discontinuous density gradient ultracentrifugation in hyperlipoproteinemic patients

    Biochem Med

    (1983)
  • J.A. Buege et al.

    Microsomal lipid peroxidation

    Methods Enzymol

    (1978)
  • M. El-Saadani et al.

    A spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent

    J Lipid Res

    (1989)
  • M. Ezaki et al.

    Lipoperoxides in LDL incubated with fibroblasts that overexpress 15-lipoxygenase

    J Lipid Res

    (1995)
  • O.H. Lowry et al.

    Protein measurement with the Folin phenol reagent

    J Biol Chem

    (1951)
  • I.B. Afanas’ev et al.

    Chelating and free radical scavenging mechanisms of inhibitory action of rutin and quercetin in lipid peroxidation

    Biochem Pharmacol

    (1989)
  • F. Guardiola et al.

    Biological effects of oxysterols: current status

    Food Chem Toxicol

    (1996)
  • B. Frei et al.

    Content of antioxidants, preformed lipid hydroperoxides, and cholesterol as predictors of the susceptibility of human LDL to metal ion-dependent and -independent oxidation

    J Lipid Res

    (1993)
  • M. Maiorino et al.

    Copper-induced lipid peroxidation in liposomes, micelles, and LDL: which is the role of vitamin E

    Free Radical Biol Med

    (1995)
  • L.L. Smith et al.

    Biological activities of oxysterols

    Free Radical Biol Med

    (1989)
  • K. Clare et al.

    Toxicity of oxysterols to human monocyte-macrophages

    Atherosclerosis

    (1995)
  • L. Kritharides et al.

    Hydroxypropyl-β-cyclodextrin-mediated efflux of 7-ketocholesterol from macrophage foam cells

    J Biol Chem

    (1996)
  • K.L.H. Carpenter et al.

    Lipids and oxidized lipids in human atherosclerotic lesions at different stages of development

    Biochim Biophys Acta

    (1995)
  • K.L.H. Carpenter et al.

    Lipids and oxidized lipids in human atheroma and normal aorta

    Biochim Biophys Acta

    (1993)
  • M.S. Jacobson

    Cholesterol oxides in Indian ghee: possible cause of unexplained high risk of atherosclerosis in Indian immigrant populations

    Lancet

    (1987)
  • K.L.H. Carpenter et al.

    Oxidation of cholesterol linoleate by human monocyte-macrophages in vitro

    Atherosclerosis

    (1990)
  • A.J. Brown et al.

    Free and esterified oxysterol: formation during copper-oxidation of low density lipoprotein and uptake by macrophages

    J Lipid Res

    (1996)
  • H. Zhang et al.

    Effects of oxidatively modified LDL on cholesterol esterification in cultured macrophages

    J Lipid Res

    (1990)
  • S. Bhadra et al.

    Oxidation of cholesterol moiety of low density lipoprotein in the presence of human endothelial cells or Cu+2 ions: identification of major products and their effects

    Biochem Biophys Res Commun

    (1991)
  • T. Wang et al.

    Formation of monohydroxy derivatives of arachidonic acid, linoleic acid, and oleic acid during oxidation of low density lipoprotein by copper ions and endothelial cells

    J Lipid Res

    (1992)
  • M.A. Livrea et al.

    Contribution of vitamin A to the oxidation resistance of human low density lipoproteins

    Free Radical Biol Med

    (1995)
  • P. Palozza et al.

    The effect of fatty acid unsaturation on the antioxidant activity of β-carotene and -tocopherol in hexane solutions

    Free Radical Biol Med

    (1995)
  • D. Steinberg et al.

    Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity

    New Engl J Med

    (1989)
  • G. Jurgens et al.

    Modification of human serum low density lipoprotein by oxidation-characterization and pathophysiological implications

    Chem Phys Lipids

    (1987)
  • H. Esterbauer et al.

    Vitamin E and other lipophilic antioxidants protect LDL against oxidation

    Fat Sci Technol

    (1989)
  • J.L. Witztum et al.

    Role of oxidized low density lipoprotein in atherogenesis

    J Clin Invest

    (1991)
  • Cited by (0)

    View full text